Published in J Periodontal Res on July 08, 2009
Microbial shift and periodontitis. Periodontol 2000 (2011) 1.33
Photodynamic therapy in dentistry: a literature review. Clin Oral Investig (2012) 1.15
Nanoparticle-based endodontic antimicrobial photodynamic therapy. J Endod (2009) 1.12
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence (2011) 1.05
Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro study. Lasers Med Sci (2010) 1.03
Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol (2013) 1.02
Phototoxic effect of blue light on the planktonic and biofilm state of anaerobic periodontal pathogens. J Periodontal Implant Sci (2013) 1.01
Photodynamic therapy in the treatment of chronic periodontitis: a systematic review and meta-analysis. Lasers Med Sci (2011) 0.99
Newer root canal irrigants in horizon: a review. Int J Dent (2011) 0.96
Antimicrobial photodynamic therapy for inactivation of biofilms formed by oral key pathogens. Front Microbiol (2014) 0.95
Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes. Photochem Photobiol (2012) 0.94
Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation. PLoS One (2012) 0.86
Susceptibility of multispecies biofilm to photodynamic therapy using Photodithazine®. Lasers Med Sci (2013) 0.82
Photodynamic effects of methylene blue-loaded polymeric nanoparticles on dental plaque bacteria. Lasers Surg Med (2011) 0.82
Antimicrobial photodynamic therapy suppresses dental plaque formation in healthy adults: a randomized controlled clinical trial. BMC Oral Health (2014) 0.82
Photodynamic therapy as a novel treatment for halitosis in adolescents: study protocol for a randomized controlled trial. Trials (2014) 0.81
In vitro effect photodynamic therapy with differents photosensitizers on cariogenic microorganisms. BMC Microbiol (2015) 0.81
Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection. Expert Rev Anti Infect Ther (2013) 0.81
Effect of Twice-Daily Blue Light Treatment on Matrix-Rich Biofilm Development. PLoS One (2015) 0.81
The impact of antimicrobial photodynamic therapy in an artificial biofilm model. Lasers Med Sci (2011) 0.80
Effect of repeated adjunctive antimicrobial photodynamic therapy on subgingival periodontal pathogens in the treatment of chronic periodontitis. Lasers Med Sci (2014) 0.80
Study of photodynamic therapy in the control of isolated microorganisms from infected wounds--an in vitro study. Lasers Med Sci (2013) 0.80
Prevention and treatment of biofilms by hybrid- and nanotechnologies. Int J Nanomedicine (2013) 0.79
Comparative evaluation of the efficacy of curcumin gel with and without photo activation as an adjunct to scaling and root planing in the treatment of chronic periodontitis: A split mouth clinical and microbiological study. J Nat Sci Biol Med (2015) 0.78
Photodynamic antimicrobial chemotherapy on Streptococcus mutans using curcumin and toluidine blue activated by a novel LED device. Lasers Med Sci (2013) 0.78
Photodynamic therapy as novel treatment for halitosis in adolescents: a case series study. J Lasers Med Sci (2014) 0.78
Antimicrobial photodynamic therapy and dental plaque: a systematic review of the literature. ScientificWorldJournal (2014) 0.77
Polymeric Nanoparticle-Based Photodynamic Therapy for Chronic Periodontitis in Vivo. Int J Mol Sci (2016) 0.77
Adjunctive effect of antimicrobial photodynamic therapy to nonsurgical periodontal treatment in smokers: a randomized clinical trial. Lasers Med Sci (2013) 0.77
The in Vitro Antimicrobial Efficacy of PDT against Periodontopathogenic Bacteria. Int J Mol Sci (2015) 0.76
Femtosecond Laser Patterning of the Biopolymer Chitosan for Biofilm Formation. Int J Mol Sci (2016) 0.75
Assessment of Photodynamic Inactivation against Periodontal Bacteria Mediated by a Chitosan Hydrogel in a 3D Gingival Model. Int J Mol Sci (2016) 0.75
Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges. IEEE Trans Nanobioscience (2016) 0.75
Antimicrobial photodynamic activity and cytocompatibility of Au25(Capt)18 clusters photoexcited by blue LED light irradiation. Int J Nanomedicine (2017) 0.75
Effect of Combined Therapy Using Diode Laser and Photodynamic Therapy on Levels of IL-17 in Gingival Crevicular Fluid in Patients With Chronic Periodontitis. J Lasers Med Sci (2016) 0.75
Effect of Antimicrobial Photodynamic Therapy as an Adjunct to Nonsurgical Treatment of Deep Periodontal Pockets: A Clinical Study. J Lasers Med Sci (2016) 0.75
Bacterial biofilms: a common cause of persistent infections. Science (1999) 40.82
The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science (1998) 19.92
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci U S A (1999) 7.86
Survival strategies of infectious biofilms. Trends Microbiol (2005) 6.73
Gene expression in Pseudomonas aeruginosa biofilms. Nature (2001) 6.70
Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother (1988) 5.10
Diffusion in biofilms. J Bacteriol (2003) 4.22
Identification of candidate periodontal pathogens and beneficial species by quantitative 16S clonal analysis. J Clin Microbiol (2005) 3.38
"Checkerboard" DNA-DNA hybridization. Biotechniques (1994) 2.70
The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther (2007) 2.59
Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol (2008) 2.35
Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother (1998) 1.79
Rapid diffusion of fluorescent tracers into Staphylococcus epidermidis biofilms visualized by time lapse microscopy. Antimicrob Agents Chemother (2005) 1.76
Lethal photosensitisation of oral bacteria and its potential application in the photodynamic therapy of oral infections. Photochem Photobiol Sci (2004) 1.53
Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother (2005) 1.40
Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. J Antimicrob Chemother (2006) 1.29
Photolysis of oral bacteria and its potential use in the treatment of caries and periodontal disease. J Appl Bacteriol (1993) 1.25
Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob Agents Chemother (2006) 1.22
Efficacy of gasiform ozone and photodynamic therapy on a multispecies oral biofilm in vitro. Eur J Oral Sci (2007) 1.22
Treatment of periodontal disease by photodisinfection compared to scaling and root planing. J Clin Dent (2007) 1.21
Oral bacteria in multi-species biofilms can be killed by red light in the presence of toluidine blue. Lasers Surg Med (2002) 1.18
Artificial dental plaque biofilm model systems. Adv Dent Res (1997) 1.15
Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. Eur J Oral Sci (2006) 1.14
Lethal photosensitization of bacteria in subgingival plaque from patients with chronic periodontitis. J Periodontal Res (1993) 1.11
Phenothiazinium based photosensitisers--photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr Drug Targets (2005) 1.10
Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol (2002) 1.10
Effect of dosimetric and physiological factors on the lethal photosensitization of Porphyromonas gingivalis in vitro. Photochem Photobiol (1997) 1.09
Molecular analysis of human oral microbiota. J Periodontal Res (2005) 1.07
An in vitro study of the use of photodynamic therapy for the treatment of natural oral plaque biofilms formed in vivo. J Photochem Photobiol B (1999) 1.05
Antibiotic resistance in an in vitro subgingival biofilm model. Oral Microbiol Immunol (2007) 1.03
Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. Oral Microbiol Immunol (1993) 1.03
Enhancement of erythrosine-mediated photodynamic therapy of Streptococcus mutans biofilms by light fractionation. J Antimicrob Chemother (2006) 1.02
Photobactericidal activity of methylene blue derivatives against vancomycin-resistant Enterococcus spp. J Antimicrob Chemother (1999) 1.00
Photodestruction of human dental plaque bacteria: enhancement of the photodynamic effect by photomechanical waves in an oral biofilm model. Lasers Surg Med (2003) 1.00
Factors influencing the susceptibility of Gram-negative bacteria to toluidine blue O-mediated lethal photosensitization. J Appl Microbiol (2002) 0.96
The interaction of lipopolysaccharides with phenothiazine dyes. Lasers Surg Med (2003) 0.93
The effect of variable energy input from a novel light source on the photoactivated bactericidal action of toluidine blue O on Streptococcus Mutans. Caries Res (2003) 0.91
Analysis of biocide transport limitation in an artificial biofilm system. J Appl Microbiol (1998) 0.89
Photomechanical drug delivery into bacterial biofilms. Pharm Res (2000) 0.88
Toluidine blue-mediated photoinactivation of periodontal pathogens from supragingival plaques. Lasers Med Sci (2007) 0.88
Growth of micro-organisms from supragingival dental plaque on saliva agar. J Dent Res (1986) 0.84
Effect of self-association and protein binding on the photochemical reactivity of triarylmethanes. Implications of noncovalent interactions on the competition between photosensitization mechanisms type I and type II. Photochem Photobiol (1999) 0.80
Antibiotic resistance of biofilms. Biofouling (1996) 0.80
Nucleotide sequence and expression of the gene encoding the EcoRII modification enzyme. Nucleic Acids Res (1987) 2.68
Life-threatening reactions after pedodontic sedation: an assessment of narcotic, local anesthetic, and antiemetic drug interaction. J Am Dent Assoc (1983) 2.64
Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area. Int J Tuberc Lung Dis (2009) 2.22
Diet and caries-associated bacteria in severe early childhood caries. J Dent Res (2010) 2.00
Microbiota of periodontal pockets losing crestal alveolar bone. J Periodontal Res (1984) 1.99
Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol Immunol (2004) 1.96
The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med (2005) 1.95
Risk appraisal of narcotic sedation for children. Anesth Prog (1986) 1.82
Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax (2007) 1.81
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene (2001) 1.67
Prevalence of associated deformities and hip pain in patients with cam-type femoroacetabular impingement. J Bone Joint Surg Br (2009) 1.66
Clonal analysis of the microbiota of severe early childhood caries. Caries Res (2010) 1.59
Localization of a human Na+,K+-ATPase alpha subunit gene to chromosome 19q12----q13.2 and linkage to the myotonic dystrophy locus. Genomics (1988) 1.55
New concepts of destructive periodontal disease. J Clin Periodontol (1984) 1.43
The association of mutans streptococci and non-mutans streptococci capable of acidogenesis at a low pH with dental caries on enamel and root surfaces. J Dent Res (1993) 1.40
The microbiota of young children from tooth and tongue samples. J Dent Res (2002) 1.38
Prostaglandin E2 levels and human periodontal disease. Prostaglandins (1974) 1.38
Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol (1982) 1.37
Microbial risk markers for childhood caries in pediatricians' offices. J Dent Res (2010) 1.35
Outcomes and costs of coronary artery bypass grafting: comparison between octogenarians and septuagenarians at a tertiary care centre. CMAJ (2001) 1.33
A longitudinal study of the growth of the New Zealand white rabbit: cumulative and biweekly incremental growth rates for body length, body weight, femoral length, and tibial length. J Orthop Res (1986) 1.32
Complement-dependent stimulation of prostaglandin synthesis and bone resorption. Science (1974) 1.31
The final pH of bacteria comprising the predominant flora on sound and carious human root and enamel surfaces. J Dent Res (1996) 1.30
Digital detection and processing of multiple quadrature harmonics for EPR spectroscopy. J Magn Reson (2010) 1.30
Mode of birth delivery affects oral microbiota in infants. J Dent Res (2011) 1.18
Cat allergen levels in public places in New Zealand. N Z Med J (1998) 1.18
Gingival fluid levels of acid and alkaline phosphatase. J Periodontal Res (1987) 1.17
Comparison of different data analyses for detecting changes in attachment level. J Clin Periodontol (1983) 1.15
Subgingival and tongue microbiota during early periodontitis. J Dent Res (2006) 1.15
Mutans streptococci and non-mutans streptococci acidogenic at low pH, and in vitro acidogenic potential of dental plaque in two different areas of the human dentition. J Dent Res (1991) 1.14
Similarity of the oral microbiota of pre-school children with that of their caregivers in a population-based study. Oral Microbiol Immunol (2002) 1.13
The effect of peripheral chemodenervation on the ventilatory response to potassium. Respir Physiol (1985) 1.11
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria. Thorax (2006) 1.11
The predominant cultivable flora of sound and carious human root surfaces. J Dent Res (1994) 1.11
The relationship between attachment level loss and alveolar bone loss. J Clin Periodontol (1984) 1.11
Antibiotic resistance of subgingival species during and after antibiotic therapy. J Clin Periodontol (2002) 1.10
Measurement of prostaglandin E in crevicular fluid. J Clin Periodontol (1981) 1.09
Periodontal disease treatment by local drug delivery. J Periodontol (1985) 1.07
A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes. Diabetologia (2008) 1.06
Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J Periodontol (1995) 1.05
Clinical, microbiological and immunological profile of healthy, gingivitis and putative active periodontal subjects. J Periodontal Res (1996) 1.04
The effect of repeated professional supragingival plaque removal on the composition of the supra- and subgingival microbiota. J Clin Periodontol (2000) 1.04
Relationship among mutans streptococci, "low-pH" bacteria, and lodophilic polysaccharide-producing bacteria in dental plaque and early enamel caries in humans. J Dent Res (2000) 1.03
Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol (1983) 1.03
Concentration of tetracycline in human gingival fluid after single doses. J Clin Periodontol (1981) 1.02
Periodontal therapy by local delivery of tetracycline. J Clin Periodontol (1979) 1.02
Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant (2007) 1.02
Clinical parameters as predictors of destructive periodontal disease activity. J Clin Periodontol (1983) 1.01
Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole. J Clin Periodontol (2001) 1.01
Articulatory abnormalities in athetoid cerebral palsy. J Speech Hear Disord (1978) 1.01
Ascorbic acid metabolism in diabetes mellitus. Metabolism (1981) 1.00
Cloning and expression of alpha-D-glucosidase and N-acetyl-beta-glucosaminidase from the periodontal pathogen, Tannerella forsythensis (Bacteroides forsythus). Oral Microbiol Immunol (2003) 1.00
A method for the geometric and densitometric standardization of intraoral radiographs. J Periodontol (1983) 0.99
Psychopathology in non-clinically referred sexually abused children. J Am Acad Child Adolesc Psychiatry (1998) 0.99
Survival and mutagenic effects of 5-azacytidine in Escherichia coli. Mutat Res (1988) 0.99
Induction of EcoRII methyltransferase: evidence for autogenous control. J Bacteriol (1993) 0.98
Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol (2000) 0.98
Sensitive assay for measuring tetracycline levels in gingival crevice fluid. Antimicrob Agents Chemother (1980) 0.97
The pH of dental plaque in its relation to early enamel caries and dental plaque flora in humans. J Dent Res (2000) 0.97
Stimulation of bone resorption by various prostaglandins in organ culture. Prostaglandins (1975) 0.96
A case study of an ataxic dysarthric: cineradiographic and spectrographic observations. J Speech Hear Disord (1975) 0.96
The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Periodontol (1986) 0.95
Differences in the subgingival microbiota of Swedish and USA subjects who were periodontally healthy or exhibited minimal periodontal disease. J Clin Periodontol (2005) 0.95
Nasal tuberculosis--an update of current clinical and laboratory investigation. J Laryngol Otol (2010) 0.95
Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems. J Periodontol (1985) 0.95
Two-dimensional gel electrophoresis analyses of pH-dependent protein expression in facultatively alkaliphilic Bacillus pseudofirmus OF4 lead to characterization of an S-layer protein with a role in alkaliphily. J Bacteriol (2000) 0.94
Association of the microbial flora of dental plaque and saliva with human root-surface caries. J Dent Res (1990) 0.94
Subgingival temperature (I). Relation to baseline clinical parameters. J Clin Periodontol (1992) 0.92
Local tetracycline delivery using hollow fiber devices in periodontal therapy. J Clin Periodontol (1979) 0.92
An evaluation of ontology exchange languages for bioinformatics. Proc Int Conf Intell Syst Mol Biol (2000) 0.92
Crystallization studies in a urothelial-lined living test tube (the catheterized female rat bladder). I. Calcium oxalate crystal adhesion to the chemically injured rat bladder. Invest Urol (1979) 0.91
The core element of the EcoRII methylase as defined by protease digestion and deletion analysis. Nucleic Acids Res (1991) 0.91
Gingival crevicular fluid antibody to oral microorganisms. I. Method of collection and analysis of antibody. J Periodontal Res (1984) 0.90
In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour. Br J Cancer (1999) 0.90
Reduction of p12DOC-1 expression is a negative prognostic indicator in patients with surgically resected oral squamous cell carcinoma. Clin Cancer Res (2001) 0.90
Sampling of microorganisms associated with periodontal disease. Oral Microbiol Immunol (1986) 0.90
Proposal to conserve the adjectival form of the specific epithet in the reclassification of Bacteroides forsythus Tanner et al. 1986 to the genus Tannerella Sakamoto et al. 2002 as Tannerella forsythia corrig., gen. nov., comb. nov. Request for an Opinion. Int J Syst Evol Microbiol (2003) 0.89
Dental caries in congenitally athymic rats. Oral Microbiol Immunol (1990) 0.89
Dehydroascorbic acid reduction in human erythrocytes. Biochem Biophys Res Commun (1979) 0.88
An approach to the definition of periodontal disease syndromes by cluster analysis. J Clin Periodontol (1982) 0.88
Levels of prostaglandin E2, thromboxane, and prostacyclin in periodontal tissues. J Periodontal Res (1983) 0.88
Climate and head form in India. Am J Hum Biol (2001) 0.88
A 4-quadrant comparative study of periodontal treatment using tetracycline-containing drug delivery fibers and scaling. J Clin Periodontol (1991) 0.87
Periodontal diagnosis. Current status and future needs. J Periodontol (1985) 0.87
Periodontal pathogens and gestational diabetes mellitus. J Dent Res (2008) 0.87
Species specificity of ribosomal proteins in eucaryotic and procaryotic organisms. Biochem Biophys Res Commun (1969) 0.87
Tetracycline fiber therapy monitored by DNA probe and cultural methods. J Periodontal Res (1991) 0.87
Clinical measurements of periodontitis. J Clin Periodontol (1986) 0.86
Interventions: vector control and public education: panel discussion. Ann N Y Acad Sci (2001) 0.86
Ascorbic acid: a scavenger of superoxide radical. Acta Vitaminol Enzymol (1983) 0.86
Tetracycline: levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses. J Periodontol (1981) 0.86
Evaluation of periodontal treatments using controlled-release tetracycline fibers: microbiological response. J Periodontol (1995) 0.86
Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex. Kidney Int (2007) 0.85
Transmural differences in respiratory capacity across the rat left ventricle in health, aging, and streptozotocin-induced diabetes mellitus: evidence that mitochondrial dysfunction begins in the subepicardium. Am J Physiol Cell Physiol (2010) 0.85
Periodontal pathogen detection in gingiva/tooth and tongue flora samples from 18- to 48-month-old children and periodontal status of their mothers. Oral Microbiol Immunol (2002) 0.85